Swami U - Search Results

1

Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor.

Bakaloudi DR, Talukder R, Makrakis D, Diamantopoulos L, Enright T, Leary JB, Patgunarajah U, Thomas VM, Swami U, Agarwal N, Jindal T, Koshkin VS, Brown JR, Barata P, Murgić J, Miletić M, Johnson J, Zakharia Y, Hui G, Drakaki A, Duran I, Buznego LA, Barrera RM, Castañeda DM, Rey-Cárdenas M, Castellano D, Nguyen CB, Park JJ, Alva A, McKay RR, Stewart TF, Epstein IB, Bellmunt J, Wright JL, Gupta S, Grivas P, Khaki AR. Bakaloudi DR, et al. Among authors: swami u. Clin Genitourin Cancer. 2024 Dec;22(6):102198. doi: 10.1016/j.clgc.2024.102198. Epub 2024 Aug 12. Clin Genitourin Cancer. 2024. PMID: 39241315

2

Immunotherapy and fatigue: what we know and what we don't know.

Azeem Khan M, Florou V, Swami U. Azeem Khan M, et al. Among authors: swami u. Oncotarget. 2021 Apr 13;12(8):719-720. doi: 10.18632/oncotarget.27946. eCollection 2021 Apr 13. Oncotarget. 2021. PMID: 33889294 Free PMC article. No abstract available.

3

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces Together.

Swami U, Zakharia Y, Zhang J. Swami U, et al. J Immunother. 2018 Oct;41(8):359-360. doi: 10.1097/CJI.0000000000000232. J Immunother. 2018. PMID: 29781826 Review.

4

Toxicities with targeted therapies after immunotherapy in metastatic melanoma.

Grogan N, Swami U, Bossler AD, Zakharia Y, Milhem M. Grogan N, et al. Among authors: swami u. Melanoma Res. 2018 Dec;28(6):600-604. doi: 10.1097/CMR.0000000000000493. Melanoma Res. 2018. PMID: 30086073 Free PMC article. Clinical Trial.

5

Advanced stage melanoma therapies: Detailing the present and exploring the future.

Luther C, Swami U, Zhang J, Milhem M, Zakharia Y. Luther C, et al. Among authors: swami u. Crit Rev Oncol Hematol. 2019 Jan;133:99-111. doi: 10.1016/j.critrevonc.2018.11.002. Epub 2018 Nov 15. Crit Rev Oncol Hematol. 2019. PMID: 30661664 Review.

6

Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma.

Swami U, Monga V, Freesmeier M, Zhang W, Bossler AD, Zakharia Y, Milhem M. Swami U, et al. Melanoma Res. 2019 Dec;29(6):643-647. doi: 10.1097/CMR.0000000000000592. Melanoma Res. 2019. PMID: 30829928 Free PMC article.

7

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.

Swami U, Grivas P, Agarwal N. Swami U, et al. Oncologist. 2019 May;24(5):580-583. doi: 10.1634/theoncologist.2019-0161. Epub 2019 Mar 29. Oncologist. 2019. PMID: 30926675 Free PMC article.

8

Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma.

Swami U, Swick B, Zakharia Y, Milhem M. Swami U, et al. Case Rep Oncol Med. 2019 Mar 7;2019:4683531. doi: 10.1155/2019/4683531. eCollection 2019. Case Rep Oncol Med. 2019. PMID: 30963012 Free PMC article.

9

Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement.

Swami U, Nussenzveig RH, Haaland B, Agarwal N. Swami U, et al. Ann Transl Med. 2019 Mar;7(Suppl 1):S18. doi: 10.21037/atm.2019.01.50. Ann Transl Med. 2019. PMID: 31032299 Free PMC article. No abstract available.

10

Ideal Glucocorticoid Regimen With Abiraterone Acetate: Options and Challenges.

Swami U, Pal SK, Agarwal N. Swami U, et al. JAMA Oncol. 2019 Aug 1;5(8):1167-1169. doi: 10.1001/jamaoncol.2019.1008. JAMA Oncol. 2019. PMID: 31246246 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters